350 related articles for article (PubMed ID: 15455498)
1. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
2. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
[TBL] [Abstract][Full Text] [Related]
3. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
5. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
Bernstein CN; Nugent Z; Blanchard JF
Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
[TBL] [Abstract][Full Text] [Related]
6. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
7. Turner's syndrome and inflammatory bowel disease: a case report with immunologic studies.
Manzione NC; Kram M; Kram E; Das KM
Am J Gastroenterol; 1988 Nov; 83(11):1294-7. PubMed ID: 3055947
[TBL] [Abstract][Full Text] [Related]
8. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Uittenbogaart SB; Klemt-Kropp M
Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
[TBL] [Abstract][Full Text] [Related]
9. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
11. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
12. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
Stange EF
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
[TBL] [Abstract][Full Text] [Related]
13. Membranous glomerulonephritis associated with ulcerative colitis.
Makhlough A; Fakheri H
Iran J Kidney Dis; 2008 Apr; 2(2):102-4. PubMed ID: 19377218
[TBL] [Abstract][Full Text] [Related]
14. [Crohn's disease and pregnancy. A case report].
Gudiño Molina FJ; Jinich Brook H; Montiel-Jarquin A; Rodríguez Torres LF
Ginecol Obstet Mex; 1998 Feb; 66():62-4. PubMed ID: 9586389
[TBL] [Abstract][Full Text] [Related]
15. The association of autoimmune disorders with inflammatory bowel disease.
Snook JA; de Silva HJ; Jewell DP
Q J Med; 1989 Sep; 72(269):835-40. PubMed ID: 2616728
[TBL] [Abstract][Full Text] [Related]
16. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
[TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
18. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
20. IgA nephropathy in association with Crohn's disease: a case report and brief review of the literature.
Filiopoulos V; Trompouki S; Hadjiyannakos D; Paraskevakou H; Kamperoglou D; Vlassopoulos D
Ren Fail; 2010 May; 32(4):523-7. PubMed ID: 20446796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]